Campos-Almazán, M.I.; Hernández-Campos, A.; Castillo, R.; Sierra-Campos, E.; Valdez-Solana, M.; Avitia-DomÃnguez, C.; Téllez-Valencia, A.
Computational Methods in Cooperation with Experimental Approaches to Design Protein Tyrosine Phosphatase 1B Inhibitors in Type 2 Diabetes Drug Design: A Review of the Achievements of This Century. Pharmaceuticals 2022, 15, 866.
https://doi.org/10.3390/ph15070866
AMA Style
Campos-Almazán MI, Hernández-Campos A, Castillo R, Sierra-Campos E, Valdez-Solana M, Avitia-DomÃnguez C, Téllez-Valencia A.
Computational Methods in Cooperation with Experimental Approaches to Design Protein Tyrosine Phosphatase 1B Inhibitors in Type 2 Diabetes Drug Design: A Review of the Achievements of This Century. Pharmaceuticals. 2022; 15(7):866.
https://doi.org/10.3390/ph15070866
Chicago/Turabian Style
Campos-Almazán, Mara Ibeth, Alicia Hernández-Campos, Rafael Castillo, Erick Sierra-Campos, Mónica Valdez-Solana, Claudia Avitia-DomÃnguez, and Alfredo Téllez-Valencia.
2022. "Computational Methods in Cooperation with Experimental Approaches to Design Protein Tyrosine Phosphatase 1B Inhibitors in Type 2 Diabetes Drug Design: A Review of the Achievements of This Century" Pharmaceuticals 15, no. 7: 866.
https://doi.org/10.3390/ph15070866
APA Style
Campos-Almazán, M. I., Hernández-Campos, A., Castillo, R., Sierra-Campos, E., Valdez-Solana, M., Avitia-DomÃnguez, C., & Téllez-Valencia, A.
(2022). Computational Methods in Cooperation with Experimental Approaches to Design Protein Tyrosine Phosphatase 1B Inhibitors in Type 2 Diabetes Drug Design: A Review of the Achievements of This Century. Pharmaceuticals, 15(7), 866.
https://doi.org/10.3390/ph15070866
